CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to EIKN

Paclitaxel + Carboplatin

Phase 3
Eikon Therapeutics, Inc. (EIKN)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Non Small Cell Lung Cancer (Squamous or Non Squamous)

View Full Landscape
Drug Information

Target Indication

Non Small Cell Lung Cancer (Squamous or Non Squamous)

Clinical Trial

NCT07365319

Last updated: 5/21/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.